Corrigendum: LCN2 Is a Potential Biomarker for Radioresistance and Recurrence in Nasopharyngeal Carcinoma

Front Oncol. 2021 Mar 18:11:670714. doi: 10.3389/fonc.2021.670714. eCollection 2021.

¹ State Key Laboratory of Oncology in South China, Department of Nasopharyngeal Carcinoma, Sun Yat-Sen University Cancer Center, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China.
² Department of Radiotherapy, Eye & ENT Hospital, Fudan University, Shanghai, China.
³ Department of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang, China.
⁴ NHC Key Laboratory of Personalized Diagnosis and Treatment of Nasopharyngeal Carcinoma (Jiangxi Cancer Hospital of Nanchang University), Nanchang, China.

Abstract

[This corrects the article DOI: 10.3389/fonc.2020.605777.].

Keywords: hypoxia-inducible factor 1-alpha; lipocalin 2; nasopharyngeal carcinoma; radioresistance; recurrence.